Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer

NCT04518280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: PD-1 antibody
DRUG: Capecitabine
DRUG: Oxaliplatin
RADIATION: Short-course radiotherapy

Sponsor

Fudan University